Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13 Neoplasms 12 Brain Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Sarcoma 3 Multiple Myeloma 3 Melanoma 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Thymus Neoplasms 2 Stomach Neoplasms 2 Sarcoma, Synovial 2 Rectal Neoplasms 2 Pain 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Neuroendocrine Tumors 2 Nasopharyngeal Carcinoma 2 Mesothelioma 2 Liposarcoma 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2 Fatigue 2 Colorectal Neoplasms 2

Interventions

Nivolumab 20 Ipilimumab 10 Surveys and Questionnaires 7 Paclitaxel 7 linrodostat 6 Standard of Care 6 Sirolimus 5 Gemcitabine 5 Bevacizumab 5 temsirolimus 4 relatlimab 4 Pemetrexed 4 Interviews as Topic 4 Docetaxel 4 Carboplatin 4 ARRY-334543 4 Vorinostat 3 Erlotinib Hydrochloride 3 Dasatinib 3 Cetuximab 3 regorafenib 2 olaparib 2 apatinib 2 anlotinib 2 abemaciclib 2 Trastuzumab 2 Sunitinib 2 Sorafenib 2 Olanzapine 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Quality of Life × Clear all

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡